# A 12 -Month, Open-label, Multi-center Study to Explore the Health Outcomes of FTY720

> **NCT01578330** · PHASE4 · COMPLETED · sponsor: **Novartis Pharmaceuticals** · enrollment: 42 (actual)

## Conditions studied

- Multiple Sclerosis
- Relapsing-Remitting

## Interventions

- **DRUG:** Fingolimod

## Key facts

- **NCT ID:** NCT01578330
- **Lead sponsor:** Novartis Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-10
- **Primary completion:** 2015-04
- **Final completion:** 2015-04
- **Target enrollment:** 42 (ACTUAL)
- **Last updated:** 2016-06-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01578330

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01578330, "A 12 -Month, Open-label, Multi-center Study to Explore the Health Outcomes of FTY720". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT01578330. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*